This study demonstrated that muscle GR signaling contributes to metabolic abnormalities in glucocorticoid excess, including muscle atrophy, systemic lipid accumulation, glucose intolerance, and hyperinsulinemia. Here, NR3C1 is linked to hyperinsulinism.